160 related articles for article (PubMed ID: 37560206)
1. Computational identification of novel signature of T2DM-induced nephropathy and therapeutic bioactive compounds from
Lawal B; Kuo YC; Onikanni SA; Chen YF; Abdulrasheed-Adeleke T; Fadaka AO; Olugbodi JO; Lukman HY; Olawale F; Mahmoud MH; Batiha GE; Wu AT; Huang HS
Am J Transl Res; 2023; 15(7):4504-4520. PubMed ID: 37560206
[TBL] [Abstract][Full Text] [Related]
2. Attenuating effects of
Yusuf AA; Lawal B; Alozieuwa UB; Onikanni AS; Lukman HY; Fadaka AO; Olawale F; Osuji O; Sani S; Owolabi MS; Adewuyi AH; Yusuf DH; Batiha GE; Ataya FS; Fouad D
Am J Transl Res; 2023; 15(10):5997-6014. PubMed ID: 37969197
[TBL] [Abstract][Full Text] [Related]
3. Preclinical anti-inflammatory and antioxidant effects of Azanza garckeana in STZ-induced glycemic-impaired rats, and pharmacoinformatics of it major phytoconstituents.
Lawal B; Sani S; Onikanni AS; Ibrahim YO; Agboola AR; Lukman HY; Olawale F; Jigam AA; Batiha GE; Babalola SB; Mostafa-Hedeab G; Lima CMG; Wu ATH; Huang HS; Conte-Junior CA
Biomed Pharmacother; 2022 Aug; 152():113196. PubMed ID: 35667233
[TBL] [Abstract][Full Text] [Related]
4. Azanza garckeana ameliorates Bisphenol A-induced reproductive toxicities in rabbit bucks.
Itodo JI; Rekwot PI; Aluwong T; Allam L; Olutimilehin Jolayemi K; Kyari S; Abah KO; Ibrahim S; Dogara MU; Yusuf AT; Musa MM; Mundi HL; Abdullahi HR
Theriogenology; 2022 Oct; 192():150-165. PubMed ID: 36099805
[TBL] [Abstract][Full Text] [Related]
5. Network pharmacology and molecular docking technology-based predictive study of the active ingredients and potential targets of rhubarb for the treatment of diabetic nephropathy.
Fu S; Zhou Y; Hu C; Xu Z; Hou J
BMC Complement Med Ther; 2022 Aug; 22(1):210. PubMed ID: 35932042
[TBL] [Abstract][Full Text] [Related]
6. Clinical efficacies, underlying mechanisms and molecular targets of Chinese medicines for diabetic nephropathy treatment and management.
Tang G; Li S; Zhang C; Chen H; Wang N; Feng Y
Acta Pharm Sin B; 2021 Sep; 11(9):2749-2767. PubMed ID: 34589395
[TBL] [Abstract][Full Text] [Related]
7. The Uterotonic Screening of the Root Extract of
Chanda A; Simwinga F; Kaonga P; Gono-Bwalya A; Prashar L
Evid Based Complement Alternat Med; 2020; 2020():8873180. PubMed ID: 33376504
[TBL] [Abstract][Full Text] [Related]
8. Network pharmacology analysis combined with experimental validation to explore the therapeutic mechanism of Schisandra Chinensis Mixture on diabetic nephropathy.
Ma Y; Deng Y; Li N; Dong A; Li H; Chen S; Zhang S; Zhang M
J Ethnopharmacol; 2023 Feb; 302(Pt A):115768. PubMed ID: 36280016
[TBL] [Abstract][Full Text] [Related]
9. Nephroprotective effect of Combretum micranthum G. Don in nicotinamide-streptozotocin induced diabetic nephropathy in rats: In-vivo and in-silico experiments.
Kpemissi M; Potârniche AV; Lawson-Evi P; Metowogo K; Melila M; Dramane P; Taulescu M; Chandramohan V; Suhas DS; Puneeth TA; S VK; Vlase L; Andrei S; Eklu-Gadegbeku K; Sevastre B; Veerapur VP
J Ethnopharmacol; 2020 Oct; 261():113133. PubMed ID: 32673708
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of Serum Micro-RNA 152-3p in Type 2 Diabetes Mellitus with a Significant Elevation in Progressive Nephropathy.
Nasser M; Ibrahim KMF; Elnabawi WM; Ahmed TM
Egypt J Immunol; 2020 Jun; 27(2):81-92. PubMed ID: 33548980
[TBL] [Abstract][Full Text] [Related]
11. Network pharmacology and molecular docking approaches to elucidate the potential compounds and targets of Saeng-Ji-Hwang-Ko for treatment of type 2 diabetes mellitus.
Ko M; Kim Y; Kim HH; Jeong S; Ahn D; Chung SJ; Kim H
Comput Biol Med; 2022 Oct; 149():106041. PubMed ID: 36049411
[TBL] [Abstract][Full Text] [Related]
12. Phospholipidomic identification of potential plasma biomarkers associated with type 2 diabetes mellitus and diabetic nephropathy.
Zhu C; Liang QL; Hu P; Wang YM; Luo GA
Talanta; 2011 Sep; 85(4):1711-20. PubMed ID: 21872008
[TBL] [Abstract][Full Text] [Related]
13. Early-onset of type 2 diabetes mellitus is a risk factor for diabetic nephropathy progression: a biopsy-based study.
Wu Y; Wang Y; Zhang J; Zhang R; Zhao L; Ren H; Zou Y; Wang T; Wang J; Zhao Y; Qin C; Xu H; Li L; Chai Z; Cooper ME; Tong N; Liu F
Aging (Albany NY); 2021 Mar; 13(6):8146-8154. PubMed ID: 33686955
[TBL] [Abstract][Full Text] [Related]
14. Review of early circulating biomolecules associated with diabetes nephropathy - Ideal candidates for early biomarker array test for DN.
Quan KY; Yap CG; Jahan NK; Pillai N
Diabetes Res Clin Pract; 2021 Dec; 182():109122. PubMed ID: 34742785
[TBL] [Abstract][Full Text] [Related]
15. Does C-reactive protein to serum Albumin Ratio correlate with diabEtic nephropathy in patients with Type 2 dIabetes MEllitus? The CARE TIME study.
Bilgin S; Kurtkulagi O; Atak Tel BM; Duman TT; Kahveci G; Khalid A; Aktas G
Prim Care Diabetes; 2021 Dec; 15(6):1071-1074. PubMed ID: 34497035
[TBL] [Abstract][Full Text] [Related]
16. [Vitamin supply of patients with type 2 diabetes mellitus complicated by nephropathy].
Vrzhesinskaya OA; Leonenko SN; Kodentsova VM; Beketova NA; Kosheleva OV; Pilipenko VV; Plotnikova OA; Alekseeva RI; Sharafetdinov KK
Vopr Pitan; 2022; 91(2):58-71. PubMed ID: 35596636
[TBL] [Abstract][Full Text] [Related]
17. Genetic variation in
Tsetsos F; Roumeliotis A; Tsekmekidou X; Alexouda S; Roumeliotis S; Theodoridis M; Thodis E; Panagoutsos S; Papanas N; Papazoglou D; Kotsa K; Yovos JG; Maltezos E; Passadakis P; Paschou P; Georgitsi M
Diab Vasc Dis Res; 2020; 17(6):1479164120970892. PubMed ID: 33164551
[TBL] [Abstract][Full Text] [Related]
18. Integrated Analysis of Single-Cell RNA-Seq and Bulk RNA-Seq Combined with Multiple Machine Learning Identified a Novel Immune Signature in Diabetic Nephropathy.
Peng YL; Zhang Y; Pang L; Dong YF; Li MY; Liao H; Li RS
Diabetes Metab Syndr Obes; 2023; 16():1669-1684. PubMed ID: 37312900
[TBL] [Abstract][Full Text] [Related]
19. Serum and urine metabolomics reveal potential biomarkers of T2DM patients with nephropathy.
Shao M; Lu H; Yang M; Liu Y; Yin P; Li G; Wang Y; Chen L; Chen Q; Zhao C; Lu Q; Wu T; Ji G
Ann Transl Med; 2020 Mar; 8(5):199. PubMed ID: 32309346
[TBL] [Abstract][Full Text] [Related]
20. Clinico-pathological features of diabetic and non-diabetic renal diseases in type 2 diabetic patients: a retrospective study from a 10-year experience in a single center.
Sun Y; Ren Y; Lan P; Yu X; Feng J; Hao D; Xie L
Int Urol Nephrol; 2023 Sep; 55(9):2303-2312. PubMed ID: 36879071
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
